58 Recruiting Refractory Acute Myeloid Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Refractory Acute Myeloid Leukemia
Top Recruiting Refractory Acute Myeloid Leukemia Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
📍 Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
📍 Rady Children's Hospital — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔